In Vivo Imaging of Human Neuroinflammation

ACS Chemical Neuroscience

Volumn 7, Issue 4, 2016, Pages 470-483

  Albrecht, Daniel S ^a   Granziera, Cristina ^a,b,c   Hooker, Jacob M ^a   Loggia, Marco L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c EPFL   (Switzerland)

Author keywords

astrocyte; blood brain barrier; brain imaging; microglia; MRS; Neuroimmunology

Indexed keywords

GADOLINIUM; LIPOCORTIN 5; TECHNETIUM 99M; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

HUMAN; IMAGE ANALYSIS; IMMUNOCOMPETENT CELL; IN VIVO STUDY; NERVOUS SYSTEM INFLAMMATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; BRAIN MAPPING; CENTRAL NERVOUS SYSTEM; DIAGNOSTIC IMAGING; INFLAMMATION; PATHOLOGY;

BRAIN MAPPING; CENTRAL NERVOUS SYSTEM; HUMANS; INFLAMMATION; NEUROIMAGING;

EID: 84966389337     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/acschemneuro.6b00056     Document Type: Review

References (143)

1. Airas, L., Rissanen, E., and Rinne, J. O. (2015) Imaging neuroinflammation in multiple sclerosis using TSPO-PET Clinical and Translational Imaging 3, 461-473 10.1007/s40336-015-0147-6
2. Heppner, F. L., Ransohoff, R. M., and Becher, B. (2015) Immune attack: the role of inflammation in Alzheimer disease Nat. Rev. Neurosci. 16, 358-372 10.1038/nrn3880
3. Littlejohn, G. (2015) Neurogenic neuroinflammation in fibromyalgia and complex regional pain syndrome Nat. Rev. Rheumatol. 11, 639-648 10.1038/nrrheum.2015.100
4. Gabuzda, D. and Yankner, B. A. (2013) Physiology: Inflammation links ageing to the brain Nature 497, 197-198 10.1038/nature12100
5. Ren, K. and Dubner, R. (2016) Activity-triggered tetrapartite neuron-glial interactions following peripheral injury Curr. Opin. Pharmacol. 26, 16-25 10.1016/j.coph.2015.09.006
6. Xanthos, D. N. and Sandkuhler, J. (2014) Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity Nat. Rev. Neurosci. 15, 43-53 10.1038/nrn3617
7. Walters, E. T. (2012) Nociceptors as chronic drivers of pain and hyperreflexia after spinal cord injury: an adaptive-maladaptive hyperfunctional state hypothesis Front. Physiol. 3, 309 10.3389/fphys.2012.00309
8. Pasternak, O., Kubicki, M., and Shenton, M. E. (2015) In vivo imaging of neuroinflammation in schizophrenia Schizophr. Res. 10.1016/j.schres.2015.05.034
9. Rathbone, A. T., Tharmaradinam, S., Jiang, S., Rathbone, M. P., and Kumbhare, D. A. (2015) A review of the neuro- and systemic inflammatory responses in post concussion symptoms: Introduction of the "post-inflammatory brain syndrome" PIBS Brain, Behav., Immun. 46, 1-16 10.1016/j.bbi.2015.02.009
10. van der Doef, T. F., Doorduin, J., van Berckel, B. N., and Cervenka, S. (2015) Assessing brain immune activation in psychiatric disorders: clinical and preclinical PET imaging studies of the 18-kDa translocator protein Clinical and Translational Imaging 3, 449-460 10.1007/s40336-015-0140-0
11. Gaitan, M. I., Shea, C. D., Evangelou, I. E., Stone, R. D., Fenton, K. M., Bielekova, B., Massacesi, L., and Reich, D. S. (2011) Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions Ann. Neurol. 70, 22-29 10.1002/ana.22472
12. Bowman, G. L. and Quinn, J. F. (2008) Alzheimer's disease and the Blood-Brain Barrier: Past, Present and Future Aging Health 4, 47-55 10.2217/1745509X.4.1.47
13. Russo, M. V. and McGavern, D. B. (2015) Immune Surveillance of the CNS following Infection and Injury Trends Immunol. 36, 637-650 10.1016/j.it.2015.08.002
14. Jacobs, A. H., Tavitian, B., and INMiND Consortium (2012) Noninvasive molecular imaging of neuroinflammation J. Cereb. Blood Flow Metab. 32, 1393-1415 10.1038/jcbfm.2012.53
15. Pulli, B. and Chen, J. W. (2014) Imaging Neuroinflammation-from Bench to Bedside J. Clin. Cell. Immunol. 5, 226 10.4172/2155-9899.1000226
16. Chesselet, M. F. and Carmichael, S. T. (2012) Animal models of neurological disorders Neurotherapeutics 9, 241-244 10.1007/s13311-012-0118-9
17. Edmondson, D. E., Binda, C., Wang, J., Upadhyay, A. K., and Mattevi, A. (2009) Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases Biochemistry 48, 4220-4230 10.1021/bi900413g
18. Tsilidis, K. K., Panagiotou, O. A., Sena, E. S., Aretouli, E., Evangelou, E., Howells, D. W., Al-Shahi Salman, R., Macleod, M. R., and Ioannidis, J. P. (2013) Evaluation of excess significance bias in animal studies of neurological diseases PLoS Biol. 11, e1001609 10.1371/journal.pbio.1001609
19. Loth, M. K., Choi, J., McGlothan, J. L., Pletnikov, M. V., Pomper, M. G., and Guilarte, T. R. (2016) TSPO in a murine model of Sandhoff disease: presymptomatic marker of neurodegeneration and disease pathophysiology Neurobiol. Dis. 85, 174-186 10.1016/j.nbd.2015.11.001
20. Pekny, M. and Pekna, M. (2014) Astrocyte reactivity and reactive astrogliosis: costs and benefits Physiol. Rev. 94, 1077-1098 10.1152/physrev.00041.2013
21. Zeis, T., Enz, L., and Schaeren-Wiemers, N. (2015) The immunomodulatory oligodendrocyte Brain Res. 10.1016/j.brainres.2015.09.021
22. Herrera-Rivero, M., Heneka, M. T., and Papadopoulos, V. (2015) Translocator protein and new targets for neuroinflammation Clinical and Translational Imaging 3, 391-402 10.1007/s40336-015-0151-x
23. Tu, L. N., Morohaku, K., Manna, P. R., Pelton, S. H., Butler, W. R., Stocco, D. M., and Selvaraj, V. (2014) Peripheral benzodiazepine receptor/translocator protein global knock-out mice are viable with no effects on steroid hormone biosynthesis J. Biol. Chem. 289, 27444-27454 10.1074/jbc.M114.578286
24. Banati, R. B., Middleton, R. J., Chan, R., Hatty, C. R., Kam, W. W., Quin, C., Graeber, M. B., Parmar, A., Zahra, D., Callaghan, P., Fok, S., Howell, N. R., Gregoire, M., Szabo, A., Pham, T., Davis, E., and Liu, G. J. (2014) Positron emission tomography and functional characterization of a complete PBR/TSPO knockout Nat. Commun. 5, 5452 10.1038/ncomms6452
25. Fan, J., Campioli, E., Midzak, A., Culty, M., and Papadopoulos, V. (2015) Conditional steroidogenic cell-targeted deletion of TSPO unveils a crucial role in viability and hormone-dependent steroid formation Proc. Natl. Acad. Sci. U. S. A. 112, 7261-7266 10.1073/pnas.1502670112
26. Cosenza-Nashat, M., Zhao, M. L., Suh, H. S., Morgan, J., Natividad, R., Morgello, S., and Lee, S. C. (2009) Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain Neuropathol. Appl. Neurobiol. 35, 306-328 10.1111/j.1365-2990.2008.01006.x
27. Chen, M. K. and Guilarte, T. R. (2008) Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair Pharmacol. Ther. 118, 1-17 10.1016/j.pharmthera.2007.12.004
28. Liu, X., Liu, H., Xu, S., Tang, Z., Xia, W., Cheng, Z., Li, W., and Jin, Y. (2016) Spinal translocator protein alleviates chronic neuropathic pain behavior and modulates spinal astrocyte-neuronal function in rats with L5 spinal nerve ligation model Pain 157, 103-116 10.1097/j.pain.0000000000000339
29. Wei, X. H., Wei, X., Chen, F. Y., Zang, Y., Xin, W. J., Pang, R. P., Chen, Y., Wang, J., Li, Y. Y., Shen, K. F., Zhou, L. J., and Liu, X. G. (2013) The upregulation of translocator protein (18 kDa) promotes recovery from neuropathic pain in rats J. Neurosci. 33, 1540-1551 10.1523/JNEUROSCI.0324-12.2013
30. Rupprecht, R., Papadopoulos, V., Rammes, G., Baghai, T. C., Fan, J., Akula, N., Groyer, G., Adams, D., and Schumacher, M. (2010) Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders Nat. Rev. Drug Discovery 9, 971-988 10.1038/nrd3295
31. Abourbeh, G., Theze, B., Maroy, R., Dubois, A., Brulon, V., Fontyn, Y., Dolle, F., Tavitian, B., and Boisgard, R. (2012) Imaging microglial/macrophage activation in spinal cords of experimental autoimmune encephalomyelitis rats by positron emission tomography using the mitochondrial 18 kDa translocator protein radioligand [(1)(8)F]DPA-714 J. Neurosci. 32, 5728-5736 10.1523/JNEUROSCI.2900-11.2012
32. Banati, R. B., Newcombe, J., Gunn, R. N., Cagnin, A., Turkheimer, F., Heppner, F., Price, G., Wegner, F., Giovannoni, G., Miller, D. H., Perkin, G. D., Smith, T., Hewson, A. K., Bydder, G., Kreutzberg, G. W., Jones, T., Cuzner, M. L., and Myers, R. (2000) The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity Brain 123, 2321-2337 10.1093/brain/123.11.2321
33. Ji, B., Maeda, J., Sawada, M., Ono, M., Okauchi, T., Inaji, M., Zhang, M. R., Suzuki, K., Ando, K., Staufenbiel, M., Trojanowski, J. Q., Lee, V. M., Higuchi, M., and Suhara, T. (2008) Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologies J. Neurosci. 28, 12255-12267 10.1523/JNEUROSCI.2312-08.2008
34. Chen, M. K. and Guilarte, T. R. (2006) Imaging the peripheral benzodiazepine receptor response in central nervous system demyelination and remyelination Toxicol. Sci. 91, 532-539 10.1093/toxsci/kfj172
35. Cosenza-Nashat, M., Zhao, M. L., Suh, H. S., Morgan, J., Natividad, R., Morgello, S., and Lee, S. C. (2009) Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain Neuropathol. Appl. Neurobiol. 35, 306-328 10.1111/j.1365-2990.2008.01006.x
36. Rojas, S., Martin, A., Arranz, M. J., Pareto, D., Purroy, J., Verdaguer, E., Llop, J., Gomez, V., Gispert, J. D., Millan, O., Chamorro, A., and Planas, A. M. (2007) Imaging brain inflammation with [(11)C]PK11195 by PET and induction of the peripheral-type benzodiazepine receptor after transient focal ischemia in rats J. Cereb. Blood Flow Metab. 27, 1975-1986 10.1038/sj.jcbfm.9600500
37. Gulyas, B., Makkai, B., Kasa, P., Gulya, K., Bakota, L., Varszegi, S., Beliczai, Z., Andersson, J., Csiba, L., Thiele, A., Dyrks, T., Suhara, T., Suzuki, K., Higuchi, M., and Halldin, C. (2009) A comparative autoradiography study in post mortem whole hemisphere human brain slices taken from Alzheimer patients and age-matched controls using two radiolabelled DAA1106 analogues with high affinity to the peripheral benzodiazepine receptor (PBR) system Neurochem. Int. 54, 28-36 10.1016/j.neuint.2008.10.001
38. Venneti, S., Lopresti, B. J., and Wiley, C. A. (2006) The peripheral benzodiazepine receptor (Translocator protein 18 kDa) in microglia: from pathology to imaging Prog. Neurobiol. 80, 308-322 10.1016/j.pneurobio.2006.10.002
39. Owen, D. R., Guo, Q., Rabiner, E. A., and Gunn, R. N. (2015) The impact of the rs6971 polymorphism in TSPO for quantification and study design Clin. Transl. Imaging 3, 417-422 10.1007/s40336-015-0141-z
40. Coughlin, J. M., Wang, Y., Munro, C. A., Ma, S., Yue, C., Chen, S., Airan, R., Kim, P. K., Adams, A. V., Garcia, C., Higgs, C., Sair, H. I., Sawa, A., Smith, G., Lyketsos, C. G., Caffo, B., Kassiou, M., Guilarte, T. R., and Pomper, M. G. (2015) Neuroinflammation and brain atrophy in former NFL players: An in vivo multimodal imaging pilot study Neurobiol. Dis. 74, 58-65 10.1016/j.nbd.2014.10.019
41. Banati, R. B., Cagnin, A., Brooks, D. J., Gunn, R. N., Myers, R., Jones, T., Birch, R., and Anand, P. (2001) Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury NeuroReport 12, 3439-3442 10.1097/00001756-200111160-00012
42. Zurcher, N. R., Loggia, M. L., Lawson, R., Chonde, D. B., Izquierdo-Garcia, D., Yasek, J. E., Akeju, O., Catana, C., Rosen, B. R., Cudkowicz, M. E., Hooker, J. M., and Atassi, N. (2015) Increased glial activation in patients with amyotrophic lateral sclerosis: Assessed with [C]-PBR28 NeuroImage. Clinical 7, 409-414 10.1016/j.nicl.2015.01.009
43. Janczar, K., Su, Z., Raccagni, I., Anfosso, A., Kelly, C., Durrenberger, P. F., Gerhard, A., and Roncaroli, F. (2015) The 18-kDa mitochondrial translocator protein in gliomas: from the bench to bedside Biochem. Soc. Trans. 43, 579-585 10.1042/BST20150064
44. Loggia, M. L., Chonde, D. B., Akeju, O., Arabasz, G., Catana, C., Edwards, R. R., Hill, E., Hsu, S., Izquierdo-Garcia, D., Ji, R. R., Riley, M., Wasan, A. D., Zurcher, N. R., Albrecht, D. S., Vangel, M. G., Rosen, B. R., Napadow, V., and Hooker, J. M. (2015) Evidence for brain glial activation in chronic pain patients Brain 138, 604 10.1093/brain/awu377
45. Niccolini, F., Su, P., and Politis, M. (2015) PET in multiple sclerosis Clinical nuclear medicine 40, e46-52 10.1097/RLU.0000000000000359
46. Owen, D. R., Howell, O. W., Tang, S. P., Wells, L. A., Bennacef, I., Bergstrom, M., Gunn, R. N., Rabiner, E. A., Wilkins, M. R., Reynolds, R., Matthews, P. M., and Parker, C. A. (2010) Two binding sites for [3H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation J. Cereb. Blood Flow Metab. 30, 1608-1618 10.1038/jcbfm.2010.63
47. Kreisl, W. C., Jenko, K. J., Hines, C. S., Lyoo, C. H., Corona, W., Morse, C. L., Zoghbi, S. S., Hyde, T., Kleinman, J. E., Pike, V. W., McMahon, F. J., Innis, R. B., and Biomarkers Consortium PET Radioligand Project Team (2013) A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation J. Cereb. Blood Flow Metab. 33, 53-58 10.1038/jcbfm.2012.131
48. Owen, D. R., Yeo, A. J., Gunn, R. N., Song, K., Wadsworth, G., Lewis, A., Rhodes, C., Pulford, D. J., Bennacef, I., Parker, C. A., StJean, P. L., Cardon, L. R., Mooser, V. E., Matthews, P. M., Rabiner, E. A., and Rubio, J. P. (2012) An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28 J. Cereb. Blood Flow Metab. 32, 1-5 10.1038/jcbfm.2011.147
49. Lockhart, A., Davis, B., Matthews, J. C., Rahmoune, H., Hong, G., Gee, A., Earnshaw, D., and Brown, J. (2003) The peripheral benzodiazepine receptor ligand PK11195 binds with high affinity to the acute phase reactant alpha1-acid glycoprotein: implications for the use of the ligand as a CNS inflammatory marker Nucl. Med. Biol. 30, 199-206 10.1016/S0969-8051(02)00410-9
50. Turkheimer, F. E., Rizzo, G., Bloomfield, P. S., Howes, O., Zanotti-Fregonara, P., Bertoldo, A., and Veronese, M. (2015) The methodology of TSPO imaging with positron emission tomography Biochem. Soc. Trans. 43, 586-592 10.1042/BST20150058
51. Logan, J., Fowler, J. S., Volkow, N. D., Wang, G. J., Ding, Y. S., and Alexoff, D. L. (1996) Distribution volume ratios without blood sampling from graphical analysis of PET data J. Cereb. Blood Flow Metab. 16, 834-840 10.1097/00004647-199609000-00008
52. Lammertsma, A. A. and Hume, S. P. (1996) Simplified reference tissue model for PET receptor studies NeuroImage 4, 153-158 10.1006/nimg.1996.0066
53. Turkheimer, F. E., Edison, P., Pavese, N., Roncaroli, F., Hammers, A., Gerhard, A., Hinz, R., Tai, Y. F., and Brooks, D. J. (2007) Reference and target region modeling of [11C]-(R)-PK11195 brain studies J. Nucl. Med. 48, 158-167
54. Bloomfield, P. S., Selvaraj, S., Veronese, M., Rizzo, G., Bertoldo, A., Owen, D. R., Bloomfield, M. A., Bonoldi, I., Kalk, N., Turkheimer, F., McGuire, P., de Paola, V., and Howes, O. D. (2016) Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [C]PBR28 PET Brain Imaging Study Am. J. Psychiatry 173, 44-52 10.1176/appi.ajp.2015.14101358
55. Lyoo, C. H., Ikawa, M., Liow, J. S., Zoghbi, S. S., Morse, C. L., Pike, V. W., Fujita, M., Innis, R. B., and Kreisl, W. C. (2015) Cerebellum Can Serve As a Pseudo-Reference Region in Alzheimer Disease to Detect Neuroinflammation Measured with PET Radioligand Binding to Translocator Protein J. Nucl. Med. 56, 701-706 10.2967/jnumed.114.146027
56. Coughlin, J. M., Wang, Y., Ma, S., Yue, C., Kim, P. K., Adams, A. V., Roosa, H. V., Gage, K. L., Stathis, M., Rais, R., Rojas, C., McGlothan, J. L., Watkins, C. C., Sacktor, N., Guilarte, T. R., Zhou, Y., Sawa, A., Slusher, B. S., Caffo, B., Kassiou, M., Endres, C. J., and Pomper, M. G. (2014) Regional brain distribution of translocator protein using [(11)C]DPA-713 PET in individuals infected with HIV J. NeuroVirol. 20, 219-232 10.1007/s13365-014-0239-5
57. Ekblom, J., Jossan, S. S., Oreland, L., Walum, E., and Aquilonius, S. M. (1994) Reactive gliosis and monoamine oxidase B Journal of neural transmission. Supplementum 41, 253-258 10.1007/978-3-7091-9324-2-33
58. Fowler, J. S., Wang, G. J., Logan, J., Xie, S., Volkow, N. D., MacGregor, R. R., Schlyer, D. J., Pappas, N., Alexoff, D. L., and Patlak, C. et al. 1995, Selective reduction of radiotracer trapping by deuterium substitution: comparison of carbon-11- l -deprenyl and carbon-11-deprenyl-D2 for MAO B mapping J. Nucl. Med. 36, 1255-1262
59. Fowler, J. S., MacGregor, R. R., Wolf, A. P., Arnett, C. D., Dewey, S. L., Schlyer, D., Christman, D., Logan, J., Smith, M., and Sachs, H. et al. 1987, Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET Science 235, 481-485 10.1126/science.3099392
60. Linnman, C., Appel, L., Fredrikson, M., Gordh, T., Soderlund, A., Langstrom, B., and Engler, H. (2011) Elevated [11C]-D-deprenyl uptake in chronic Whiplash Associated Disorder suggests persistent musculoskeletal inflammation PLoS One 6, e19182 10.1371/journal.pone.0019182
61. Scholl, M., Carter, S. F., Westman, E., Rodriguez-Vieitez, E., Almkvist, O., Thordardottir, S., Wall, A., Graff, C., Langstrom, B., and Nordberg, A. (2015) Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography Sci. Rep. 5, 16404 10.1038/srep16404
62. Johansson, A., Engler, H., Blomquist, G., Scott, B., Wall, A., Aquilonius, S. M., Langstrom, B., and Askmark, H. (2007) Evidence for astrocytosis in ALS demonstrated by [11C](L)-deprenyl-D2 PET J. Neurol. Sci. 255, 17-22 10.1016/j.jns.2007.01.057
63. Saura, J., Bleuel, Z., Ulrich, J., Mendelowitsch, A., Chen, K., Shih, J. C., Malherbe, P., Da Prada, M., and Richards, J. G. (1996) Molecular neuroanatomy of human monoamine oxidases A and B revealed by quantitative enzyme radioautography and in situ hybridization histochemistry Neuroscience 70, 755-774 10.1016/S0306-4522(96)83013-2
64. Aid, S. and Bosetti, F. (2011) Targeting cyclooxygenases-1 and -2 in neuroinflammation: Therapeutic implications Biochimie 93, 46-51 10.1016/j.biochi.2010.09.009
65. Yagami, T., Koma, H., and Yamamoto, Y. (2015) Pathophysiological Roles of Cyclooxygenases and Prostaglandins in the Central Nervous System Mol. Neurobiol. 1-18 10.1007/s12035-015-9355-3
66. Shukuri, M., Takashima-Hirano, M., Tokuda, K., Takashima, T., Matsumura, K., Inoue, O., Doi, H., Suzuki, M., Watanabe, Y., and Onoe, H. (2011) In vivo expression of cyclooxygenase-1 in activated microglia and macrophages during neuroinflammation visualized by PET with 11C-ketoprofen methyl ester J. Nucl. Med. 52, 1094-1101 10.2967/jnumed.110.084046
67. Ohnishi, A., Senda, M., Yamane, T., Sasaki, M., Mikami, T., Nishio, T., Ikari, Y., Nishida, H., Shukuri, M., Takashima, T., Mawatari, A., Doi, H., Watanabe, Y., and Onoe, H. (2014) Human whole-body biodistribution and dosimetry of a new PET tracer, [(11)C]ketoprofen methyl ester, for imagings of neuroinflammation Nucl. Med. Biol. 41, 594-599 10.1016/j.nucmedbio.2014.04.008
68. Soliman, M. L., Ohm, J. E., and Rosenberger, T. A. (2013) Acetate reduces PGE2 release and modulates phospholipase and cyclooxygenase levels in neuroglia stimulated with lipopolysaccharide Lipids 48, 651-662 10.1007/s11745-013-3799-x
69. Font-Nieves, M., Sans-Fons, M. G., Gorina, R., Bonfill-Teixidor, E., Salas-Perdomo, A., Marquez-Kisinousky, L., Santalucia, T., and Planas, A. M. (2012) Induction of COX-2 enzyme and down-regulation of COX-1 expression by lipopolysaccharide (LPS) control prostaglandin E2 production in astrocytes J. Biol. Chem. 287, 6454-6468 10.1074/jbc.M111.327874
70. Farooqui, A. A., Horrocks, L. A., and Farooqui, T. (2007) Modulation of inflammation in brain: a matter of fat J. Neurochem. 101, 577-599 10.1111/j.1471-4159.2006.04371.x
71. Esposito, G., Giovacchini, G., Liow, J. S., Bhattacharjee, A. K., Greenstein, D., Schapiro, M., Hallett, M., Herscovitch, P., Eckelman, W. C., Carson, R. E., and Rapoport, S. I. (2008) Imaging neuroinflammation in Alzheimer's disease with radiolabeled arachidonic acid and PET J. Nucl. Med. 49, 1414-1421 10.2967/jnumed.107.049619
72. Henry, R. J., Kerr, D. M., Finn, D. P., and Roche, M. (2014) FAAH-mediated modulation of TLR3-induced neuroinflammation in the rat hippocampus J. Neuroimmunol. 276, 126-134 10.1016/j.jneuroim.2014.09.002
73. Rebola, N., Simoes, A. P., Canas, P. M., Tome, A. R., Andrade, G. M., Barry, C. E., Agostinho, P. M., Lynch, M. A., and Cunha, R. A. (2011) Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction J. Neurochem. 117, 100-111 10.1111/j.1471-4159.2011.07178.x
74. Orr, A. G., Orr, A. L., Li, X. J., Gross, R. E., and Traynelis, S. F. (2009) Adenosine A(2A) receptor mediates microglial process retraction Nat. Neurosci. 12, 872-878 10.1038/nn.2341
75. Mishina, M. and Ishiwata, K. (2014) Adenosine receptor PET imaging in human brain Int. Rev. Neurobiol. 119, 51-69 10.1016/B978-0-12-801022-8.00002-7
76. Rissanen, E., Virta, J. R., Paavilainen, T., Tuisku, J., Helin, S., Luoto, P., Parkkola, R., Rinne, J. O., and Airas, L. (2013) Adenosine A2A receptors in secondary progressive multiple sclerosis: a [(11)C]TMSX brain PET study J. Cereb. Blood Flow Metab. 33, 1394-1401 10.1038/jcbfm.2013.85
77. Gotti, C., Zoli, M., and Clementi, F. (2006) Brain nicotinic acetylcholine receptors: native subtypes and their relevance Trends Pharmacol. Sci. 27, 482-491 10.1016/j.tips.2006.07.004
78. Martin, A., Szczupak, B., Gomez-Vallejo, V., Domercq, M., Cano, A., Padro, D., Munoz, C., Higuchi, M., Matute, C., and Llop, J. (2015) In vivo PET imaging of the alpha4beta2 nicotinic acetylcholine receptor as a marker for brain inflammation after cerebral ischemia J. Neurosci. 35, 5998-6009 10.1523/JNEUROSCI.3670-14.2015
79. Sabri, O., Becker, G. A., Meyer, P. M., Hesse, S., Wilke, S., Graef, S., Patt, M., Luthardt, J., Wagenknecht, G., Hoepping, A., Smits, R., Franke, A., Sattler, B., Habermann, B., Neuhaus, P., Fischer, S., Tiepolt, S., Deuther-Conrad, W., Barthel, H., Schonknecht, P., and Brust, P. (2015) First-in-human PET quantification study of cerebral alpha4beta2∗ nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine NeuroImage 118, 199-208 10.1016/j.neuroimage.2015.05.065
80. Chang, L., Munsaka, S. M., Kraft-Terry, S., and Ernst, T. (2013) Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain J. Neuroimmune Pharmacol 8, 576-593 10.1007/s11481-013-9460-x
81. Brand, A., Richter-Landsberg, C., and Leibfritz, D. (1993) Multinuclear NMR studies on the energy metabolism of glial and neuronal cells Dev. Neurosci. 15, 289-298 10.1159/000111347
82. Fisher, S. K., Novak, J. E., and Agranoff, B. W. (2002) Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance J. Neurochem. 82, 736-754 10.1046/j.1471-4159.2002.01041.x
83. Grover, V. P., Pavese, N., Koh, S. B., Wylezinska, M., Saxby, B. K., Gerhard, A., Forton, D. M., Brooks, D. J., Thomas, H. C., and Taylor-Robinson, S. D. (2012) Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammation Journal of viral hepatitis 19, e89-96 10.1111/j.1365-2893.2011.01510.x
84. Butteriss, D. J., Ismail, A., Ellison, D. W., and Birchall, D. (2003) Use of serial proton magnetic resonance spectroscopy to differentiate low grade glioma from tumefactive plaque in a patient with multiple sclerosis Br. J. Radiol. 76, 662-665 10.1259/bjr/85069069
85. Harris, J. L., Yeh, H. W., Choi, I. Y., Lee, P., Berman, N. E., Swerdlow, R. H., Craciunas, S. C., and Brooks, W. M. (2012) Altered neurochemical profile after traumatic brain injury: (1)H-MRS biomarkers of pathological mechanisms J. Cereb. Blood Flow Metab. 32, 2122-2134 10.1038/jcbfm.2012.114
86. Prichard, J., Rothman, D., Novotny, E., Petroff, O., Kuwabara, T., Avison, M., Howseman, A., Hanstock, C., and Shulman, R. (1991) Lactate rise detected by 1H NMR in human visual cortex during physiologic stimulation Proc. Natl. Acad. Sci. U. S. A. 88, 5829-5831 10.1073/pnas.88.13.5829
87. Lopez-Villegas, D., Lenkinski, R. E., Wehrli, S. L., Ho, W. Z., and Douglas, S. D. (1995) Lactate production by human monocytes/macrophages determined by proton MR spectroscopy Magn. Reson. Med. 34, 32-38 10.1002/mrm.1910340107
88. Magistretti, P. J. (2009) Role of glutamate in neuron-glia metabolic coupling Am. J. Clin. Nutr. 90, 875S-880S 10.3945/ajcn.2009.27462CC
89. Meyerhoff, D. J., Bloomer, C., Cardenas, V., Norman, D., Weiner, M. W., and Fein, G. (1999) Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients Neurology 52, 995-1003 10.1212/WNL.52.5.995
90. Zahr, N. M., Mayer, D., Rohlfing, T., Sullivan, E. V., and Pfefferbaum, A. (2014) Imaging neuroinflammation? A perspective from MR spectroscopy Brain Pathol. 24, 654-664 10.1111/bpa.12197
91. Buonocore, M. H. and Maddock, R. J. (2015) Magnetic resonance spectroscopy of the brain: a review of physical principles and technical methods Rev. Neurosci. 26, 609-632 10.1515/revneuro-2015-0010
92. Jacobs, M. A., Horska, A., van Zijl, P. C., and Barker, P. B. (2001) Quantitative proton MR spectroscopic imaging of normal human cerebellum and brain stem Magn. Reson. Med. 46, 699-705 10.1002/mrm.1248
93. Barker, P. B., Soher, B. J., Blackband, S. J., Chatham, J. C., Mathews, V. P., and Bryan, R. N. (1993) Quantitation of proton NMR spectra of the human brain using tissue water as an internal concentration reference NMR Biomed. 6, 89-94 10.1002/nbm.1940060114
94. Hennig, J., Pfister, H., Ernst, T., and Ott, D. (1992) Direct absolute quantification of metabolites in the human brain with in vivo localized proton spectroscopy NMR Biomed. 5, 193-199 10.1002/nbm.1940050406
95. Roser, W., Steinbrich, W., and Radue, E. W. (1997) Results and consequences of frequent quality control of quantitative clinical 1H-MR-spectroscopy RoFo: Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 166, 554-557 10.1055/s-2007-1015476
96. Ramadan, S., Andronesi, O. C., Stanwell, P., Lin, A. P., Sorensen, A. G., and Mountford, C. E. (2011) Use of in vivo two-dimensional MR spectroscopy to compare the biochemistry of the human brain to that of glioblastoma Radiology 259, 540-549 10.1148/radiol.11101123
97. Andronesi, O. C., Gagoski, B. A., and Sorensen, A. G. (2012) Neurologic 3D MR spectroscopic imaging with low-power adiabatic pulses and fast spiral acquisition Radiology 262, 647-661 10.1148/radiol.11110277
98. Abbott, N. J., Ronnback, L., and Hansson, E. (2006) Astrocyte-endothelial interactions at the blood-brain barrier Nat. Rev. Neurosci. 7, 41-53 10.1038/nrn1824
99. McCaffrey, G., Staatz, W. D., Sanchez-Covarrubias, L., Finch, J. D., Demarco, K., Laracuente, M. L., Ronaldson, P. T., and Davis, T. P. (2012) P-glycoprotein trafficking at the blood-brain barrier altered by peripheral inflammatory hyperalgesia J. Neurochem. 122, 962-975 10.1111/j.1471-4159.2012.07831.x
100. Liu, L., Collier, A. C., Link, J. M., Domino, K. B., Mankoff, D. A., Eary, J. F., Spiekerman, C. F., Hsiao, P., Deo, A. K., and Unadkat, J. D. (2015) Modulation of P-glycoprotein at the Human Blood-Brain Barrier by Quinidine or Rifampin Treatment: A Positron Emission Tomography Imaging Study Drug Metab. Dispos. 43, 1795-1804 10.1124/dmd.114.058685
101. Doorduin, J., de Vries, E. F., Dierckx, R. A., and Klein, H. C. (2014) P-glycoprotein activity in the blood-brain barrier is affected by virus-induced neuroinflammation and antipsychotic treatment Neuropharmacology 85, 548-553 10.1016/j.neuropharm.2014.06.017
102. Heye, A. K., Culling, R. D., Valdes Hernandez, M. d. C., Thrippleton, M. J., and Wardlaw, J. M. (2014) Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review NeuroImage: Clinical 6, 262-274 10.1016/j.nicl.2014.09.002
103. Sourbron, S. P. and Buckley, D. L. (2013) Classic models for dynamic contrast-enhanced MRI NMR Biomed. 26, 1004-1027 10.1002/nbm.2940
104. Mirasol, R. V., Bokkers, R. P., Hernandez, D. A., Merino, J. G., Luby, M., Warach, S., and Latour, L. L. (2014) Assessing reperfusion with whole-brain arterial spin labeling: a noninvasive alternative to gadolinium Stroke 45, 456-461 10.1161/STROKEAHA.113.004001
105. Liu, H. L., Chang, T. T., Yan, F. X., Li, C. H., Lin, Y. S., and Wong, A. M. (2015) Assessment of vessel permeability by combining dynamic contrast-enhanced and arterial spin labeling MRI NMR Biomed. 28, 642-649 10.1002/nbm.3297
106. Absinta, M., Vuolo, L., Rao, A., Nair, G., Sati, P., Cortese, I. C., Ohayon, J., Fenton, K., Reyes-Mantilla, M. I., Maric, D., Calabresi, P. A., Butman, J. A., Pardo, C. A., and Reich, D. S. (2015) Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis Neurology 85, 18-28 10.1212/WNL.0000000000001587
107. Lopes Pinheiro, M. A., Kooij, G., Mizee, M. R., Kamermans, A., Enzmann, G., Lyck, R., Schwaninger, M., Engelhardt, B., and de Vries, H. E. (2016) Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke Biochim. Biophys. Acta, Mol. Basis Dis. 1862, 461-471 10.1016/j.bbadis.2015.10.018
108. Wohleb, E. S., McKim, D. B., Sheridan, J. F., and Godbout, J. P. (2015) Monocyte trafficking to the brain with stress and inflammation: a novel axis of immune-to-brain communication that influences mood and behavior Front. Neurosci. 8, 447 10.3389/fnins.2014.00447
109. Wunder, A., Klohs, J., and Dirnagl, U. (2009) Non-invasive visualization of CNS inflammation with nuclear and optical imaging Neuroscience 158, 1161-1173 10.1016/j.neuroscience.2008.10.005
110. Kelsen, J., Agnholt, J., Falborg, L., Nielsen, J. T., Romer, J. L., Hoffmann, H. J., and Dahlerup, J. F. (2004) Indium-labelled human gut-derived T cells from healthy subjects with strong in vitro adhesion to MAdCAM-1 show no detectable homing to the gut in vivo Clin. Exp. Immunol. 138, 66-74 10.1111/j.1365-2249.2004.02578.x
111. Van Hemert, F. J., Voermans, C., Van Eck-Smit, B. L., and Bennink, R. J. (2009) Labeling monocytes for imaging chronic inflammation Q. J. Nucl. Med. Mol. Imaging 53, 78-88
112. Kircher, M. F., Gambhir, S. S., and Grimm, J. (2011) Noninvasive cell-tracking methods Nat. Rev. Clin. Oncol. 8, 677-688 10.1038/nrclinonc.2011.141
113. Neuwelt, A., Sidhu, N., Hu, C. A., Mlady, G., Eberhardt, S. C., and Sillerud, L. O. (2015) Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation AJR, Am. J. Roentgenol. 204, W302-313 10.2214/AJR.14.12733
114. Walter, H. L., Walberer, M., Rueger, M. A., Backes, H., Wiedermann, D., Hoehn, M., Neumaier, B., Graf, R., Fink, G. R., and Schroeter, M. (2015) In vivo analysis of neuroinflammation in the late chronic phase after experimental stroke Neuroscience 292, 71-80 10.1016/j.neuroscience.2015.02.024
115. Nighoghossian, N., Wiart, M., Cakmak, S., Berthezene, Y., Derex, L., Cho, T. H., Nemoz, C., Chapuis, F., Tisserand, G. L., Pialat, J. B., Trouillas, P., Froment, J. C., and Hermier, M. (2007) Inflammatory response after ischemic stroke: a USPIO-enhanced MRI study in patients Stroke 38, 303-307 10.1161/01.STR.0000254548.30258.f2
116. Normandin, M. D., Yuan, H., Wilks, M. Q., Chen, H. H., Kinsella, J. M., Cho, H., Guehl, N. J., Absi-Halabi, N., Hosseini, S. M., El Fakhri, G., Sosnovik, D. E., and Josephson, L. (2015) Heat-Induced Radiolabeling of Nanoparticles for Monocyte Tracking by PET Angew. Chem., Int. Ed. 54, 13002-13006 10.1002/anie.201505525
117. Stankoff, B., Freeman, L., Aigrot, M. S., Chardain, A., Dolle, F., Williams, A., Galanaud, D., Armand, L., Lehericy, S., Lubetzki, C., Zalc, B., and Bottlaender, M. (2011) Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-(1)(1)C]-2-(4′-methylaminophenyl)- 6-hydroxybenzothiazole Ann. Neurol. 69, 673-680 10.1002/ana.22320
118. Fodero-Tavoletti, M. T., Rowe, C. C., McLean, C. A., Leone, L., Li, Q. X., Masters, C. L., Cappai, R., and Villemagne, V. L. (2009) Characterization of PiB binding to white matter in Alzheimer disease and other dementias J. Nucl. Med. 50, 198-204 10.2967/jnumed.108.057984
119. Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergstrom, M., Savitcheva, I., Huang, G. F., Estrada, S., Ausen, B., Debnath, M. L., Barletta, J., Price, J. C., Sandell, J., Lopresti, B. J., Wall, A., Koivisto, P., Antoni, G., Mathis, C. A., and Langstrom, B. (2004) Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B Ann. Neurol. 55, 306-319 10.1002/ana.20009
120. Veronese, M., Bodini, B., Garcia-Lorenzo, D., Battaglini, M., Bongarzone, S., Comtat, C., Bottlaender, M., Stankoff, B., and Turkheimer, F. E. (2015) Quantification of [(11)C]PIB PET for imaging myelin in the human brain: a test-retest reproducibility study in high-resolution research tomography J. Cereb. Blood Flow Metab. 35, 1771-1782 10.1038/jcbfm.2015.120
121. Baron, J. C., Yamauchi, H., Fujioka, M., and Endres, M. (2014) Selective neuronal loss in ischemic stroke and cerebrovascular disease J. Cereb. Blood Flow Metab. 34, 2-18 10.1038/jcbfm.2013.188
122. Pascual, B., Prieto, E., Arbizu, J., Marti-Climent, J. M., Penuelas, I., Quincoces, G., Zarauza, R., Pappata, S., and Masdeu, J. C. (2012) Decreased carbon-11-flumazenil binding in early Alzheimer's disease Brain 135, 2817-2825 10.1093/brain/aws210
123. Giffard, C., Landeau, B., Kerrouche, N., Young, A. R., Barre, L., and Baron, J. C. (2008) Decreased chronic-stage cortical 11C-flumazenil binding after focal ischemia-reperfusion in baboons: a marker of selective neuronal loss? Stroke 39, 991-999 10.1161/STROKEAHA.107.489419
124. Vivash, L., Gregoire, M. C., Bouilleret, V., Berard, A., Wimberley, C., Binns, D., Roselt, P., Katsifis, A., Myers, D. E., Hicks, R. J., O'Brien, T. J., and Dedeurwaerdere, S. (2014) In vivo measurement of hippocampal GABAA/cBZR density with [18F]-flumazenil PET for the study of disease progression in an animal model of temporal lobe epilepsy PLoS One 9, e86722 10.1371/journal.pone.0086722
125. Zhang, S., Boyd, J., Delaney, K., and Murphy, T. H. (2005) Rapid reversible changes in dendritic spine structure in vivo gated by the degree of ischemia J. Neurosci. 25, 5333-5338 10.1523/JNEUROSCI.1085-05.2005
126. Zeng, W., Wang, X., Xu, P., Liu, G., Eden, H. S., and Chen, X. (2015) Molecular imaging of apoptosis: from micro to macro Theranostics 5, 559-582 10.7150/thno.11548
127. Hoglund, J., Shirvan, A., Antoni, G., Gustavsson, S. A., Langstrom, B., Ringheim, A., Sorensen, J., Ben-Ami, M., and Ziv, I. (2011) 18F-ML-10, a PET tracer for apoptosis: first human study J. Nucl. Med. 52, 720-725 10.2967/jnumed.110.081786
128. Challapalli, A., Kenny, L. M., Hallett, W. A., Kozlowski, K., Tomasi, G., Gudi, M., Al-Nahhas, A., Coombes, R. C., and Aboagye, E. O. (2013) 18F-ICMT-11, a caspase-3-specific PET tracer for apoptosis: biodistribution and radiation dosimetry J. Nucl. Med. 54, 1551-1556 10.2967/jnumed.112.118760
129. Doss, M., Kolb, H. C., Walsh, J. C., Mocharla, V., Fan, H., Chaudhary, A., Zhu, Z., Alpaugh, R. K., Lango, M. N., and Yu, J. Q. (2013) Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteers J. Nucl. Med. 54, 2087-2092 10.2967/jnumed.113.119800
130. Cauda, F., Palermo, S., Costa, T., Torta, R., Duca, S., Vercelli, U., Geminiani, G., and Torta, D. M. (2014) Gray matter alterations in chronic pain: A network-oriented meta-analytic approach NeuroImage. Clinical 4, 676-686 10.1016/j.nicl.2014.04.007
131. Matsuda, H. (2016) MRI morphometry in Alzheimer's disease Ageing Res. Rev. 10.1016/j.arr.2016.01.003
132. Frodl, T. and Amico, F. (2014) Is there an association between peripheral immune markers and structural/functional neuroimaging findings? Prog. Neuro-Psychopharmacol. Biol. Psychiatry 48, 295-303 10.1016/j.pnpbp.2012.12.013
133. Kreisl, W. C., Lyoo, C. H., McGwier, M., Snow, J., Jenko, K. J., Kimura, N., Corona, W., Morse, C. L., Zoghbi, S. S., Pike, V. W., McMahon, F. J., and Turner, R. S. (2013) In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease Brain 136, 2228-2238 10.1093/brain/awt145
134. Zhou, G., Hotta, J., Lehtinen, M. K., Forss, N., and Hari, R. (2015) Enlargement of choroid plexus in complex regional pain syndrome Sci. Rep. 5, 14329 10.1038/srep14329
135. Maddock, R. J. and Buonocore, M. H. (2011) MR spectroscopic studies of the brain in psychiatric disorders Curr. Top. Behav. Neurosci. 11, 199-251 10.1007/7854-2011-197
136. Granziera, C. and Sprenger, T. (2015) Brain Inflammation, Degeneration, and Plasticity in Multiple Sclerosis. In Brain Mapping: An Encyclopedic Reference (Toga, A. W., Ed.), pp 917-927, Academic Press, Waltham, MA.
137. Bonnier, G., Roche, A., Romascano, D., Simioni, S., Meskaldji, D., Rotzinger, D., Lin, Y. C., Menegaz, G., Schluep, M., Du Pasquier, R., Sumpf, T. J., Frahm, J., Thiran, J. P., Krueger, G., and Granziera, C. (2014) Advanced MRI unravels the nature of tissue alterations in early multiple sclerosis Ann. Clin. Transl. Neurol. 1, 423-432 10.1002/acn3.68
138. Bonnier, G., Roche, A., Romascano, D., Simioni, S., Meskaldji, D. E., Rotzinger, D., Lin, Y. C., Menegaz, G., Schluep, M., Du Pasquier, R., Sumpf, T. J., Frahm, J., Thiran, J. P., Krueger, G., and Granziera, C. (2015) Multicontrast MRI Quantification of Focal Inflammation and Degeneration in Multiple Sclerosis BioMed Res. Int. 2015, 569123 10.1155/2015/569123
139. Enzinger, C., Barkhof, F., Ciccarelli, O., Filippi, M., Kappos, L., Rocca, M. A., Ropele, S., Rovira, A., Schneider, T., de Stefano, N., Vrenken, H., Wheeler-Kingshott, C., Wuerfel, J., Fazekas, F., and MAGNIMS study group (2015) Nonconventional MRI and microstructural cerebral changes in multiple sclerosis Nat. Rev. Neurol. 11, 676-686 10.1038/nrneurol.2015.194
140. Klawiter, E. C., Schmidt, R. E., Trinkaus, K., Liang, H. F., Budde, M. D., Naismith, R. T., Song, S. K., Cross, A. H., and Benzinger, T. L. (2011) Radial diffusivity predicts demyelination in ex vivo multiple sclerosis spinal cords NeuroImage 55, 1454-1460 10.1016/j.neuroimage.2011.01.007
141. Sepehrband, F., Clark, K. A., Ullmann, J. F., Kurniawan, N. D., Leanage, G., Reutens, D. C., and Yang, Z. (2015) Brain tissue compartment density estimated using diffusion-weighted MRI yields tissue parameters consistent with histology Human brain mapping 36, 3687-3702 10.1002/hbm.22872
142. Colasanti, A., Guo, Q., Muhlert, N., Giannetti, P., Onega, M., Newbould, R. D., Ciccarelli, O., Rison, S., Thomas, C., Nicholas, R., Muraro, P. A., Malik, O., Owen, D. R., Piccini, P., Gunn, R. N., Rabiner, E. A., and Matthews, P. M. (2014) In Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with (18)F-PBR111 PET J. Nucl. Med. 55, 1112-1118 10.2967/jnumed.113.135129
143. Ma, D., Gulani, V., Seiberlich, N., Liu, K., Sunshine, J. L., Duerk, J. L., and Griswold, M. A. (2013) Magnetic resonance fingerprinting Nature 495, 187-192 10.1038/nature11971